According to Suven Life Sciences latest financial reports the total liabilities of SUVEN is $1.62M, an increase of 14.32% to 2022. At the end of 2022 company had $1.42M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Suven Life Sciences is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $1.62M | 14.32% |
2022 | $1.42M | -41.75% |
2021 | $2.43M | -47.10% |
2020 | $4.60M | -61.31% |
2019 | $11.89M | - |